Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Verma, Subodh; Bain, Stephen C.; Fries, Tea Monk; Mazer, C. David; Nauck, Michael A.; Pratley, Richard E.; Rasmussen, Søren; Saevereid, Hans A.; Zinman, Bernard; Buse, John B.; Bain, Steve

doi:10.1111/dom.13698

Journal article 742 views 109 downloads

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Subodh Verma, Stephen C. Bain, Tea Monk Fries, C. David Mazer, Michael A. Nauck, Richard E. Pratley, Søren Rasmussen, Hans A. Saevereid, Bernard Zinman, John B. Buse, Steve Bain

Diabetes, Obesity and Metabolism

Swansea University Author: Steve Bain

PDF | Version of Record

Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).
Download (1011.33KB)

Check full text

DOI (Published version): 10.1111/dom.13698

Published in:	Diabetes, Obesity and Metabolism
ISSN:	1462-8902 1463-1326
Published:	2019
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa49876

Description
Staff View

College:	Faculty of Medicine, Health and Life Sciences

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Similar Items